1. Targeting Hypoxia-Inducible Factors for the Treatment of Anemia in Chronic Kidney Disease Patients
Locatelli et al. Am J Nephrol 2017;45:   (DOI: / )
Fig. 1. The role of hepcidin, iron, and erythropoietin in erythropoiesis. CKD, chronic kidney disease; EPO, erythropoietin.

2. Targeting Hypoxia-Inducible Factors for the Treatment of Anemia in Chronic Kidney Disease Patients
Locatelli et al. Am J Nephrol 2017;45:   (DOI: / )
Fig. 2. a, b HIF activity under normoxic/hypoxic conditions and HIF-PHI inhibition, and its effects on erythropoiesis. DCytB, duodenal cytochrome B; DMT1, Divalent metal transporter 1; EPO, erythropoietin; HIF, hypoxia-inducible factor; HIF-PH, hypoxia-inducible factor-prolyl-4-hydroxylase domain; HRE, HIF-responsive element; Pro, proline.

3. Targeting Hypoxia-Inducible Factors for the Treatment of Anemia in Chronic Kidney Disease Patients
Locatelli et al. Am J Nephrol 2017;45:   (DOI: / )
Table 1. HIF-PHIs in clinical development